产前糖皮质激素给药时机与极早产儿生存:一项全国人群队列研究
基于瑞典2004年4月1日至2007年3月31日全国产科与新生儿单元的前瞻性人群队列,纳入707例22-26周活产儿,分析产前糖皮质激素(ACS)首次给药至分娩间隔与生存的关系。与给药后48小时至7天分娩相比,未暴露、<24小时及>7天分娩的婴儿生存率更低,24-47小时组无显著差异;无重大新生儿疾病的生存率在未暴露组为14%,暴露组为30-39%。
要点
- 极早产儿暴露于ACS后24小时至7天分娩,生存率显著高于未暴露及间隔过短或过长者。
- 未暴露ACS的婴儿生存率显著低于给药后48小时至7天分娩者(HR=0.26,95%CI 0.15-0.43)。
- 无重大新生儿疾病的生存率:未暴露组14%,ACS暴露组30-39%,提示任何ACS暴露均有价值。
核心结论
- 极早产前24小时至7天给予ACS与显著更高的生存率相关,优于未暴露及给药至分娩间隔更短或更长者。
研究设计与样本
- 前瞻性人群队列研究,纳入瑞典全部产科与新生儿单元2004年4月1日至2007年3月31日期间22-26周活产儿707例。
- 采用Cox比例风险回归分析首次ACS给药至分娩时间与生存的关系。
主要发现
- 591例(84%)婴儿暴露于ACS。
- 最终校正模型中,与给药后48小时至7天分娩相比,未暴露ACS婴儿生存率更低(HR=0.26,95%CI 0.15-0.43)。
- 与给药后48小时至7天分娩相比,<24小时分娩者生存率更低(HR=0.53,95%CI 0.33-0.87),>7天分娩者生存率更低(HR=0.56,95%CI 0.32-0.97)。
- 与给药后48小时至7天分娩相比,24-47小时分娩者生存率无显著差异(HR=1.60,95%CI 0.73-3.50)。
- 新生儿生存结果与婴儿生存结果相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the association between administration-to-birth interval of antenatal corticosteroids (ACS) and survival in extremely preterm infants. DESIGN: Population-based prospective cohort study. SETTING: All obstetric and neonatal units in Sweden from 1 April 2004 to 31 March 2007. POPULATION: All live-born infants (n = 707) born at 22-26 completed weeks of gestation. METHODS: The relationship between time from first administration of ACS to delivery and survival was investigated using Cox proportional hazards regression analysis. MAIN OUTCOME MEASURES: Neonatal (0-27 days) and infant (0-365 days) survival, and infant survival without major neonatal morbidity (intraventricular haemorrhage grade ≥ 3, retinopathy of prematurity stage ≥ 3, periventricular leukomalacia, necrotising enterocolitis, or severe bronchopulmonary dysplasia). RESULTS: Five-hundred and ninety-one (84%) infants were exposed to ACS. In the final adjusted model, infant survival was lower in infants unexposed to ACS [hazard ratio (HR) = 0.26; 95% confidence interval 0.15-0.43], in infants born <24 h [HR = 0.53 (0.33-0.87)] and >7 days after ACS [HR = 0.56 (0.32-0.97)], but not in infants born 24-47 h after ACS [HR = 1.60 (0.73-3.50)], as compared with infants born 48 h to 7 days after administration. The findings were similar for neonatal survival. Survival without major neonatal morbidity among live-born infants was 14% in unexposed infants and 30-39% in steroid-exposed groups, indicating that any ACS exposure was valuable. CONCLUSIONS: Administration of ACS 24 h to 7 days before extremely preterm birth was associated with significantly higher survival than in unexposed infants and in infants exposed to ACS at shorter or longer administration-to-birth intervals. TWEETABLE ABSTRACT: Timing of antenatal corticosteroids is important for extremely preterm infants' survival.
引用
- Norberg H, Kowalski J, Maršál K, et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG. 2017. PMID: 28294496. doi:10.1111/1471-0528.14545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。